Mather Group’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.6K Hold
235
﹤0.01% 1300
2026
Q1
$25.7K Buy
+235
New +$22.4K ﹤0.01% 1224
2025
Q4
Sell
-119
Closed -$10.4K 1222
2025
Q3
$10.4K Buy
+119
New +$10.6K ﹤0.01% 1263
2025
Q2
Sell
-125
Closed -$10.5K 1247
2025
Q1
$10.5K Hold
125
﹤0.01% 1245
2024
Q4
$11.5K Buy
+125
New +$12K ﹤0.01% 1213
2024
Q2
Sell
-51
Closed -$2.9K 2246
2024
Q1
$2.9K Buy
+51
New +$3.15K ﹤0.01% 1470

Other funds holding LMAT

Mather Group's LMAT Position: Q2 2026 in Review

Mather Group held its LeMaitre Vascular (LMAT) position steady in Q2 2026 at 235 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1300.

Mather Group first reported a position in LMAT in Q1 2024 and has held it in 6 quarters since. The position peaked at $25.7K in Q1 2026. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Mather Group held 235 shares of LeMaitre Vascular worth $22.6K as of Q2 2026.
  • Mather Group left its LeMaitre Vascular share count unchanged in Q2 2026.
  • LeMaitre Vascular made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1300 holding.
  • Mather Group first reported a position in LeMaitre Vascular in Q1 2024 and has held it in 6 quarters since.
  • Mather Group's LeMaitre Vascular position peaked at $25.7K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.